Profiling microRNA from nephrectomy and biopsy specimens: predictors of progression and survival in clear cell renal cell carcinoma

To identify microRNA (miRNA) characteristic of metastatic clear cell renal cell carcinoma (ccRCC) and those indicative of cancer‐specific survival (CSS) in nephrectomy and biopsy specimens. We also sought to determine if a miRNA panel could differentiate benign from ccRCC tissue.

[1]  J. Speakman,et al.  Renal cell carcinoma survival and body mass index: a dose–response meta-analysis reveals another potential paradox within a paradox , 2016, International Journal of Obesity.

[2]  Jun Yao,et al.  The association between abnormal microRNA-10b expression and cancer risk: a meta-analysis , 2014, Scientific Reports.

[3]  Kathleen A Cronin,et al.  The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. , 2014, Cancer.

[4]  D. Lindgren,et al.  The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma. , 2014, European journal of cancer.

[5]  Sören Müller,et al.  Exploring the miRNA-mRNA Regulatory Network in Clear Cell Renal Cell Carcinomas by Next-Generation Sequencing Expression Profiles , 2014, BioMed research international.

[6]  Il-man Kim,et al.  Regulation of Metastasis by microRNAs in Ovarian Cancer , 2014, Front. Oncol..

[7]  P. Franco,et al.  The Role of microRNA in Head and Neck Cancer: Current Knowledge and Perspectives , 2014, Molecules.

[8]  Karthik Devarajan,et al.  MicroRNA expression signatures of stage, grade, and progression in clear cell RCC , 2014, Cancer biology & therapy.

[9]  Qingxia Wei,et al.  MicroRNAs in gastric cancer metastasis. , 2014, Critical reviews in eukaryotic gene expression.

[10]  Marcus Stapf,et al.  MicroRNAs with Prognostic Potential for Metastasis in Clear Cell Renal Cell Carcinoma: A Comparison of Primary Tumors and Distant Metastases , 2014, Annals of Surgical Oncology.

[11]  L. Antunes,et al.  MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis , 2013, British Journal of Cancer.

[12]  Xiangxiang Zhou,et al.  Role of microRNAs in chronic lymphocytic leukemia (Review). , 2013, Molecular medicine reports.

[13]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.

[14]  E. Meiri,et al.  Development and validation of a microRNA‐based diagnostic assay for classification of renal cell carcinomas , 2013, Molecular oncology.

[15]  Lei Zhang,et al.  The complex roles of microRNAs in the metastasis of renal cell carcinoma. , 2013, Journal of nanoscience and nanotechnology.

[16]  K. Schaser,et al.  Identification of Metastamirs as Metastasis-associated MicroRNAs in Clear Cell Renal Cell Carcinomas , 2012, International journal of biological sciences.

[17]  A. Gerger,et al.  MicroRNAs in renal cell carcinoma: implications for pathogenesis, diagnosis, prognosis and therapy. , 2012, Anticancer research.

[18]  R. Figlin,et al.  Identification of a 4-microRNA Signature for Clear Cell Renal Cell Carcinoma Metastasis and Prognosis , 2012, PloS one.

[19]  V. Bilim,et al.  Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3β. , 2012, Cancer letters.

[20]  槻木 真明.  Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3β , 2012 .

[21]  M. Esteller.  Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.

[22]  George M Yousef,et al.  Accurate molecular classification of kidney cancer subtypes using microRNA signature. , 2011, European urology.

[23]  K. Junker,et al.  Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma , 2011, World Journal of Urology.

[24]  Huiqing Liu,et al.  Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma , 2010, BMC Systems Biology.

[25]  M. Kattan,et al.  Preoperative nomogram predicting 12-year probability of metastatic renal cancer. , 2008, The Journal of urology.

[26]  R. Uzzo,et al.  Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review. , 2008, The Journal of urology.

[27]  R. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.

[28]  G. Macino,et al.  The Role of MicroRNAs in Chronic Lymphocytic Leukemia , 2007 .

[29]  A. Antonelli,et al.  The follow‐up management of non‐metastatic renal cell carcinoma: definition of a surveillance protocol , 2007, BJU international.

[30]  D. Hosmer,et al.  Model‐Building Strategies and Methods for Logistic Regression , 2005 .

[31]  Rodney X. Sturdivant,et al.  Applied Logistic Regression: Hosmer/Applied Logistic Regression , 2005 .

[32]  Claus Lindbjerg Andersen,et al.  Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets , 2004, Cancer Research.

[33]  C. Lynch,et al.  Improved survival of follicular lymphoma patients in the surveillance, epidemiology, and end-results (SEER) program , 2004 .

[34]  R. Figlin,et al.  Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. , 2003, The Urologic clinics of North America.

[35]  R. Figlin,et al.  Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  M. Kattan,et al.  A postoperative prognostic nomogram for renal cell carcinoma. , 2001, The Journal of urology.

[37]  M. Karno,et al.  Renal cell carcinoma. , 1956, Bulletin. Tufts-New England Medical Center.

[38]  W. Youden,et al.  Index for rating diagnostic tests , 1950, Cancer.